Synlett 2008(8): 1129-1132  
DOI: 10.1055/s-2008-1072716
LETTER
© Georg Thieme Verlag Stuttgart · New York

An Efficient One-Pot Synthesis of 1H-Pyrazolo[1,2-b]phthalazine-5,10-dione Derivatives

Ramin Ghahremanzadeh, Ghazaleh Imani Shakibaei, Ayoob Bazgir*
Department of Chemistry, Shahid Beheshti University, P. O. Box 19396-4716, Tehran, Iran
e-Mail: a_bazgir@sbu.ac.ir;
Weitere Informationen

Publikationsverlauf

Received 21 January 2008
Publikationsdatum:
16. April 2008 (online)

Abstract

An efficient, three-component, one-pot condensation reaction between phthalhydrazide, aromatic aldehydes, and malononitrile or ethyl cyanoacetate for the synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives in excellent yields is reported.

    References and Notes

  • 1 Strecker A. Liebigs Ann. Chem.  1850,  75:  27 
  • 2 Dömling A. Ugi I. Angew. Chem. Int. Ed.  2000,  39:  3168 
  • 3 Kappe CO. Acc. Chem. Res.  2000,  33:  879 
  • 4 Terrett NK. Bell AS. Brown D. Ellis P. Bioorg. Med. Chem. Lett.  1996,  6:  1819 
  • 5 Elguero J. In Comprehensive Heterocyclic Chemistry II   Vol. 3:  Katritzky AR. Rees CW. Scriven EF. Elsevier; Oxford: 1996.  p.1-75  
  • 6 Singh SK. Reddy PG. Rao KS. Lohray BB. Misra P. Rajjak SA. Rao YK. Venkatewarlu A. Bioorg. Med. Chem. Lett.  2004,  14:  499 
  • 7 Genin MJ. Biles C. Keiser BJ. Poppe SM. Swaney SM. Tarpley WG. Yagi Y. Romero DL. J. Med. Chem.  2000,  43:  1034 
  • 8 Al’-Assar F. Zelenin KN. Lesiovskaya EE. Bezhan IP. Chakchir BA. Pharm. Chem. J.  2002,  36:  598 
  • 9 Jain RP. Vederas JC. Bioorg. Med. Chem. Lett.  2004,  14:  3655 
  • 10 Carling RW. Moore KW. Street LJ. Wild D. Isted C. Leeson PD. Thomas S. O’Conner D. McKernan RM. Quirk K. Cook SM. Atack JR. Waftord KA. Thompson SA. Dawson GR. Ferris P. Castro JL.
    J. Med. Chem.  2004,  47:  1807 
  • 11 Grasso S. DeSarro G. Micale N. Zappala M. Puia G. Baraldi M. Demicheli C. J. Med. Chem.  2000,  43:  2851 
  • 12 Nomoto Y. Obase H. Takai H. Teranishi M. Nakamura J. Kubo K. Chem. Pharm. Bull.  1990,  38:  2179 
  • 13 Watanabe N. Kabasawa Y. Takase Y. Matsukura M. Miyazaki K. Ishihara H. Kodama K. Adachi H. J. Med. Chem.  1998,  41:  3367 
  • 14 Razvi M. Ramalingam T. Sattur PB. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1989,  28:  695 
  • 15 Agarwal A. Chauhan PMS. Tetrahedron Lett.  2005,  46:  1345 
  • 16 Wang X.-S. Zhang M.-M. Jiang H. Yao C.-S. Tu S.-J. Tetrahedron  2007,  63:  4439 
  • 17 Maggi R. Ballini R. Sartori G. Sartorio R. Tetrahedron Lett.  2004,  45:  2297 
  • 18 Magedov IV. Manpadi M. Evdokimov NM. Elias EM. Rozhkova E. Ogasavara MA. Bettale JD. Przheval’ski NM. Rogelj S. Kornienko A. Bioorg. Med. Chem. Lett.  2007,  17:  3872 
  • 19 Wang X.-S. Shi D.-Q. Wei X.-Y. Zong Z.-M. J. Chem. Res.  2004,  679 
  • 20a Sayyafi M. Seyyedhamzeh M. Khavasi HR. Bazgir A. Tetrahedron  2008,  in press
  • 20b Dabiri M. Arvin-Nezhad H. Bazgir A. Tetrahedron  2007,  63:  1770 
  • 20c Dabiri M. Delbari AS. Bazgir A. Synlett  2007,  821 
  • 20d Dabiri M. Delbari AS. Bazgir A. Heterocycles  2007,  71:  543 
  • 20e Amini MM. Shaabani A. Bazgir A. Catal. Commun.  2006,  7:  843 
  • 20f Bazgir A. Seyyedhamzeh M. Yasaei Z. Mirzaei P. Tetrahedron Lett.  2007,  48:  8790 
21

Typical Procedure for the Preparation of 3-Amino-5,10-dihydro-5,10-dioxo-1-phenyl-1 H -pyrazolo[1,2- b ]phthalazin-2-carbonitrile (7a)
A mixture of malononitrile (1 mmol), phthalhydrazide (1 mmol), benzaldehyde (1 mmol), PTSA (0.3 mmol), and [bmim]Br (0.30 g) was heated at 100 °C for 3 h (TLC). After cooling, the reaction mixture was washed with H2O (15 mL) and residue recrystallized from MeOH to afford the pure product 7a. Yellow powder (94%); mp 276-278 °C. IR (KBr): νmax = 3359, 3190, 2197, 1690, 1658 cm-1. MS (EI, 70 eV): m/z (%) = 316 (20) [M+], 299 (42), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.13 (1 H, s, CH), 7.29-7.47 (5 H, m, ArH), 7.93-8.26 (4 H, m, ArH), 8.09 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 62.4, 63.6, 116.1, 127.2, 127.3, 127.7, 128.7, 128.9, 129.2, 134.1, 135.1, 138.7, 151.2, 154.2, 157.1 ppm. Anal. Calcd (%) for C18H12N4O2: C, 68.35; H, 3.82; N, 17.71. Found: C, 68.41; H, 3.87; N, 17.78.

22

Selected Characterization Data
3-Amino-1-(2-chlorophenyl)-5,10-dihydro-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carbonitrile (7b)
Yellow powder (88%); mp 259-262 °C. IR (KBr): νmax = 3370, 3176, 2207, 1695, 1658 cm-1. MS (EI, 70 eV): m/z
(%) = 350 (17) [M+], 333 (44), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.46 (1 H, s, CH), 7.33-7.62 (4 H, m, ArH), 7.87-8.30 (4 H, m, ArH), 8.15 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 60.2, 61.0, 116.2, 127.2, 127.8, 128.3, 128.8, 129.2, 130.2, 130.4, 131.7, 134.3, 135.2, 135.8, 151.6, 154.0, 157.1 ppm. Anal. Calcd (%) for C18H11ClN4O2: C, 61.64; H, 3.16; N, 15.97. Found: C, 61.57; H, 3.11; N, 15.91.
3-Amino-1-(4-chlorophenyl)-5,10-dihydro-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carbonitrile (7c)
Yellow powder (91%); mp 270-272 °C. IR (KBr): νmax = 3375, 3264, 2200, 1662, 1655 cm-1. MS (EI, 70 eV): m/z
(%) = 350 (8) [M+], 333 (27), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.15 (1 H, s, CH), 7.41-7.53 (4 H, m, ArH), 7.93-8.26 (4 H, m, ArH), 8.13 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 61.3, 62.7, 116.4, 127.1, 127.7, 128.9, 129.3, 133.3, 134.2, 135.1, 137.9, 151.2, 154.1, 157.1 ppm. Anal. Calcd (%) for C18H11ClN4O2: C, 61.64; H, 3.16; N, 15.97. Found: C, 61.56; H, 3.09; N, 15.92.
Ethyl 3-Amino-5,10-dihydro-1-(3-nitrophenyl)-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7k)
Yellow powder (93%); mp 239-240 °C. IR (KBr): νmax = 3360, 3249, 1693, 1651, 1613 cm-1. MS (EI, 70 eV): m/z
(%) = 408 (23) [M+], 286 (100), 240 (40), 162 (85). 1H NMR (300 MHz, DMSO-d 6): δ = 0.99 (3 H, t, 3 J HH = 9.2 Hz, CH3), 3.94 (2 H, q, 3 J HH = 7.8 Hz, OCH2), 6.22 (1 H, s, CH), 7.56-8.30 (10 H, m, NH2 and ArH), 8.26-8.27 ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 14.51, 59.19, 63.10, 81.12, 122.58, 123.12, 127.14, 127.69, 129.09, 129.49, 129.99, 134.17, 134.56, 135.05, 142.61, 147.95, 150.52, 153.93, 157.39, 164.31 ppm. Anal. Calcd (%) for C20H16N4O6: C, 58.82; H, 3.95; N, 13.72. Found: C, 58.88; H, 3.89; N, 13.66.
Ethyl 3-Amino-5,10-dihydro-1-(4-nitrophenyl )-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7l)
Yellow powder (95%); mp 241-243 °C. IR (KBr): νmax = 3386, 3210, 1694, 1655, 1630 cm-1. MS (EI, 70 eV): m/z
(%) = 408 (13) [M+], 286 (81), 240 (17), 162 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 1.03 (3 H, t, 3 J HH = 6.8 Hz, CH3), 3.95 (2 H, q, 3 J HH = 6.7Hz, OCH2), 6.18 (1 H, s, CH), 7.73-8.29 (10 H, m, NH2 and ArH) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 14.61, 59.27, 63.04, 81.18, 123.59, 125.58, 127.16, 127.73, 129.02, 129.25, 133.04, 134.22, 135.12, 147.34, 147.77, 153.81, 157.32, 164.26 ppm. Anal. Calcd (%) for C20H16N4O6: C, 58.82; H, 3.95; N, 13.72. Found: C, 58.75; H, 3.90; N, 13.78.
Ethyl 3-Amino-5,10-dihydro-5,10-dioxo-1-p-tolyl-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7m)
Yellow powder (73%); mp 204-206 °C. IR (KBr): νmax = 3447, 3333, 1706, 1658, 1624 cm-1. MS (EI, 70 eV): m/z
(%) = 377 (27) [M+], 286 (100), 240 (25), 162 (10). 1H NMR (300 MHz, DMSO-d 6): δ = 1.04 (3 H, t, 3 J HH = 8.9 Hz, CH3), 2.25 (3 H, s, CH3), 3.96 (2 H, q, 3 J HH = 9.0 Hz, OCH2), 6.04 (1 H, s, CH), 7.07-7.38 (4 H, m, ArH), 7.69 (2 H, br s, NH2), 7.92-8.27 (4 H, m, ArH). 13C NMR (75 MHz, DMSO-d 6):
δ = 14.66, 21.17, 59.12, 63.45, 82.17, 127.11, 127.71, 128.93, 129.18, 129.34, 134.05, 135.11, 137.23, 137.26, 150.13, 153.49, 157.22, 164.55. Anal. Calcd (%) for C21H19N3O4: C, 66.83; H, 5.07; N, 11.13. Found: C, 66.88; H, 5.01; N, 11.19.